Factors determining the response to treatment in patients with vestibular migraine

References

• Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo. J Neurol. 2016;263(Suppl 1):S82–S89.
   PubMed Web of Science ®Google Scholar
• Lempert T, Olesen J, Furman J, et al. Vestibular migraine: diagnostic criteria. J Vest Res. 2012;22(4):167–172.
   PubMed Web of Science ®Google Scholar
• Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–715.
   PubMed Web of Science ®Google Scholar
• Radtke A, von Brevern M, Neuhauser H, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–1614.
   PubMed Web of Science ®Google Scholar
• Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;2:103–108.
   Google Scholar
• Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782–1786.
   PubMed Web of Science ®Google Scholar
• Baier B, Winkenwerder E, Dieterich M. “Vestibular migraine”: effects of prophylactic therapy with various drugs. A retrospective study. J Neurol. 2009;256:436–442.
   PubMed Web of Science ®Google Scholar
• Gode S, Celebisoy N, Kirazlı T, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84.
   PubMed Web of Science ®Google Scholar
• Lepcha A, Amalanathan S, Augustine AM, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–2936.
   PubMed Web of Science ®Google Scholar
• Salviz M, Yuce T, Acar H, et al. Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial. Laryngoscope. 2016;126(1):169–174.
   PubMed Web of Science ®Google Scholar
• Taghdiri F, Togha M, Razeghi JS, et al. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Springerplus. 2014;3(1):231.
   PubMedGoogle Scholar
• Teggi R, Colombo B, Gatti O, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci. 2015;36(10):1869–1873.
   PubMed Web of Science ®Google Scholar
• Celebisoy N, Gökçay F, Karahan C, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273(10):2947–2951.
   PubMed Web of Science ®Google Scholar
• Power L, Shute W, McOwan B, et al. Clinical characteristics and treatment choice in vestibular migraine. J Clin Neurosci. 2018;52:50–5327.
   PubMed Web of Science ®Google Scholar
• Arnold, M. Headache classification committee of the international headache society (IHS) the international classification of headache disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1–211.
   Web of Science ®Google Scholar
• Decalmer PB, Chatterjee SS, Cruickshank JM, et al. Beta-blockers and asthma. British Heart J. 1978;40(2):184–189.
   PubMedGoogle Scholar
• Bisdorff A. Management of vestibular migraine. Ther Adv Neurol Disord. 2011;4(3):183–191.
   PubMedGoogle Scholar
• Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the turkish version of DN4. J Pain. 2010 November;11(11):1129–1135.
   PubMed Web of Science ®Google Scholar
• Lee JW, Jung JY, Chung YS, et al. Clinical manifestation and prognosis of vestibular migraine according to the vestibular function test results. Korean J Audiol. 2013;17(1):18–22.
   PubMedGoogle Scholar
• Jung JH, Yoo MH, Song CI, et al. Prognostic significance of vestibulospinal abnormalities in patients with vestibular migraine. Otol Neurotol. 2015;36(2):282Y288.
   Web of Science ®Google Scholar
• American Headache Society. The American headache society position statement on integrating new migraine treatments into clinical practice. Headache. 2019 Jan;59(1):1–18.
   PubMed Web of Science ®Google Scholar
• Jackson JL, Cogbill E, Santana-Davila R, et al. A comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache. PLoS One. 2015;10(7):e0130733.
   PubMed Web of Science ®Google Scholar
• Maldonado Fernandez M, Birdi JS, Irving GJ, et al. Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev. 2015;6(6):CD010600.
   Google Scholar
• Liu YF, Macias D, Donaldson L, et al. Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine. J Layrngol Otol. 2020; 1–6. DOI:10.1017/S002221512000095X.
   PubMed Web of Science ®Google Scholar
• Dornhoffer JR, Liu YF, Donaldson L, et al. Factors implicated in response to treatment/prognosis of vestibular migraine. Eur Arch Otorhinolaryngol. 2020 May 24;278(1):57–66.
   PubMed Web of Science ®Google Scholar
• Buse DC, Loder EW, Gorman JA, et al. Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of theAmerican migraine prevalence and prevention (AMPP) study. Headache. 2013;53(8):1278–1299. [PubMed:23808666.].
   PubMed Web of Science ®Google Scholar
• Dieterich M, Brandt T. Episodic vertigo related to migraine. J Neurol. 1999;246(10):883–892.
   PubMed Web of Science ®Google Scholar
• Neuhauser H, Leopold M, von Brevern M, et al. The interrelations of migraine, vertigo and migrainous vertigo. Neurology. 2001;56(4):436–441.
   PubMed Web of Science ®Google Scholar
• Amandusson A, Blomqvist A. Estrogenic influences in pain processing. Front Neuroendocrinol. 2013;34(4):329–349. [PubMed: 23817054].
   PubMed Web of Science ®Google Scholar
• Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth. 2013;111:52–58. [PubMed: 23794645].
   PubMed Web of Science ®Google Scholar
• Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol. 2014;35(1):8–30. [PubMed: 23994581].
   PubMed Web of Science ®Google Scholar
• Bolay H, Özge A, Sağınç P, et al. Gender influences headache characteristics with increasing age in migraine patients. Cephalalgia. 2015 Aug;35(9):792–800.
   PubMed Web of Science ®Google Scholar
• Lipton LB, Munjal S, Alam A, et al. Migraine in America symptoms and treatment (MAST) study: baseline study methods, treatment patterns, and gender differences. Headache. 2018 Oct;58(9):1408–1426.
   PubMed Web of Science ®Google Scholar
• Lovati C, D’Amico D, Bertora P. Allodynia in migraine: frequent random association or unavoidable consequence? Expert Rev Neurother. 2009;9(3):395–408.
   PubMed Web of Science ®Google Scholar
• Burstein R, Collins B, Jakubowski M Collins B and Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol. 2004;55(1):19–26.
   PubMed Web of Science ®Google Scholar
• Bigal ME, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 2008;70(17):1525–1533.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63(2):148–158.
   PubMed Web of Science ®Google Scholar
• Tietjen GE, Brandes JL, Peterlin BL, et al. Allodynia in migraine: association with comorbid pain conditions. Headache. 2009;49(9):1333–1344.
   PubMed Web of Science ®Google Scholar
• Dodick DW, Reedd ML, Fanning KM. Predictors of allodynia in persons with migraine: results from the migraine in America symptoms and treatment (MAST) study. Cephalalgia. 2019;39(7):873–882.
   PubMed Web of Science ®Google Scholar
• Louter MA, Bosker JE, van Oosterhout WPJ, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain. 2013;136:3489–3496.
   PubMed Web of Science ®Google Scholar
• Neff BA, Staab JP, Eggers SD, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–1244.
   PubMed Web of Science ®Google Scholar
• Cohen JM, Bigal ME, Newman LC. Migraine and vestibular symptoms—identifying clinical features that predict “vestibular migraine”. Headache. 2011;51(9):1393–1397.
   PubMed Web of Science ®Google Scholar
• Eckhardt-Henn A, Best C, Bense S, et al. Psychiatric comorbidity in different organic vertigo syndromes. J Neurol. 2008;255(3):420–428.
   PubMed Web of Science ®Google Scholar
• Kutay O, Akdal G, Keskinoglu P, et al. Vestibular migraine patients are more anxious than migraine patients without vestibular symptoms. J Neurol. 2017;264(S1):37–41.
   PubMed Web of Science ®Google Scholar
• Beh SC. Vestibular migraine: how to sort it out and what to do about it. Neuroophthalmol. 2019;39(2):208–219.
   Web of Science ®Google Scholar
• Balcı B, Akdal G. Imbalance, motion sensitivity, anxiety and handicap in vestibular migraine and migraine only patients. Auris Nasus Larynx. 2020;47(5):747–751.
   PubMed Web of Science ®Google Scholar
• Vitkovic J, Winoto A, Rance G, et al. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–3048DOI.
   PubMed Web of Science ®Google Scholar
• Aydın İ, Gökçay F, Karapolat H, et al. Effects of vestibular rehabilitation and pharmacological therapy in patients with vestibular migraine. Neurol Sci Neurophysiol. 2020;37(3):110–117.
   Web of Science ®Google Scholar
• Alghadir AH, Anwer S. Effects of vestibular rehabilitation in the management of a vestibular migraine: a review. Front Neurol. 2018;9:440.
   PubMed Web of Science ®Google Scholar
• Radtke A, Lempert T, Gresty MA, et al. Migraine and Ménière’s disease Is there a link? Neurology. 2002;59(11):1700–1704.
   PubMed Web of Science ®Google Scholar
• Brantberg K, Baloh RW. Similarity of vertigo attacks due to Meniere’s disease and benign recurrent vertigo, both with and without migraine. Acta Otolaryngol. 2011;131(7):722–727.
   PubMed Web of Science ®Google Scholar
• Ghavami Y, Mahboubi H, Yau AY, et al. Migraine features in patients with Meniere’s disease. Laryngoscope. 2016;126(1):163–168.
   PubMed Web of Science ®Google Scholar
• Murofushi T, Tsubota M, Kitao K, et al. Simultaneous presentation of definite vestibular migraine and definite Ménière’s disease: overlapping syndrome of two diseases. Front Neurol. 2018;9:749.
   PubMed Web of Science ®Google Scholar
• Neff BA, Staab JP, Eggers SD, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière’s disease, vestibular migraine, and Ménière’s disease with concomitant vestibular migraine. Otol Neurotol. 2012 Sep;33(7):3039–3048.
   Web of Science ®Google Scholar